ReviewBiology2025
Role and Mechanisms of Angiogenesis in Tumours.
Review in Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Effect of extracellular vesicles on malignant tumours: Mechanisms and clinical findings (Review).Oncology letters · 2026Review
- Review
- Review
- A Vascular Invasion-Related Gene Signature Identifies NUP35 as a Driver of Angiogenesis and Poor Prognosis in Pancreatic Ductal Adenocarcinoma.Biomedicines · 2026Article
- Article
- Inhibition of VEGFJournal of chemical information and modeling · 2026Article
- Angiogenesis, Inflammation, and Oxidative Stress: Interrelationships in Autoimmune Thyroid Diseases.International journal of molecular sciences · 2026Article
- Abnormal Galectin Signaling in the Pathomechanisms of Placental Dysfunction in Gestational Diabetes Mellitus.International journal of molecular sciences · 2026Review
- Stromal ARHGEF15 Correlates With Inflammatory EMT and Stromal-Immune Crosstalk During Inflammatory Bowel Disease-To-Colorectal Cancer Progression.Bioinformatics and biology insights · 2026Article
- Neurovascular Signaling at the Gliovascular Interface: From Flow Regulation to Cognitive Energy Coupling.International journal of molecular sciences · 2025Review
- Evaluation of Antiproliferative Activity and Molecular Modeling Studies of Some Novel Benzimidazolone-Bridged Hybrid Compounds.Pharmaceuticals (Basel, Switzerland) · 2025Article
- The Interplay Between Esophageal Adenocarcinoma and Its Tumor Microenvironment: Toward Innovative Therapies.Cells · 2025Review
- Insights into the pro-angiogenic effect of hydroxysafflor yellow A (HSYA): targeting HIF-1α and MMP9 in HMEC-1.Frontiers in chemistry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article presents the accurate and current state of knowledge regarding the process of angiogenesis in neoplastic cells and its importance for tumour development. It provides a detailed review of the different types of angiogenesis with a brief discussion of individual angiogenic factors. Pathological angiogenesis in tumour tissues and the production of angiogenic factors have been recognised as key features responsible for cancerous development and distant metastasis formation since 1971. A phenomenon known as an angiogenic switch allows neoplasm to transform from an avascular to a vascular phase. The emerging new network of blood vessels allows cancer cells to efficiently exchange gases, provide nutrients and eliminate metabolic waste products. The main factors stimulating the angiogenesis process are VEGF, FGF, EGF, PDGF, and TGF-β1. To date, the most specific, strongest and most widely studied factor is VEGF. It is regarded as the main mitogen for vascular endothelial cells, stimulating their proliferation, and it is therefore referred to as a survival factor for cancer cells. Several mechanisms of new blood-vessel formation in cancerous tissue have also been identified. The three dominant processes include vascular sprouting, intussusceptive angiogenesis and vessel co-option. Angiogenesis in cancer tissues remains a subject of numerous scientific studies. A thorough understanding of the mechanism of oncogenesis and tumour expansion appears to be the starting point for future research aimed at finding effective anti-cancer therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.